{"pmid":32357275,"title":"Strategies for Prevention and Control of the 2019 Novel Coronavirus Disease in the Department of Kidney Transplantation.","text":["Strategies for Prevention and Control of the 2019 Novel Coronavirus Disease in the Department of Kidney Transplantation.","OBJECTIVE: To summarize measures for prevention and control of the 2019 novel Corona Virus Disease (COVID-19) in the department of kidney transplantation. METHODS: We retrospectively analyzed the clinical data of outpatients and inpatients in the department of kidney transplantation from January 20, 2020 to March 1, 2020, and followed up the in-home kidney transplant recipients and those waiting for kidney transplantation through the Internet platform. Our department had formulated detailed prevention and control measures, mainly including: kidney transplant outpatient management, kidney transplantation ward management, management of kidney transplant surgery, dialysis management of patients waiting for kidney transplantation, personal protection of medical staff, follow-up management of discharged patients after kidney transplantation, etc. RESULTS: During the epidemic period, there were no COVID-19 among 68 outpatient examined kidney transplant recipients, 32 hospitalized kidney transplant recipients, 19 patients waiting for kidney transplantation in hospital and 30 medical staff. There were no COVID-19 in the follow-up of 160 recipients after kidney transplantation and 60 patients waiting for kidney transplantation. CONCLUSION: During the epidemic period, we implemented strict prevention and control measures and adjusted working methods and procedures to ensure the safe and orderly work of the department.","Transpl Int","Li, Yurong","Yang, Ning","Li, Xiaoxiao","Wang, Junpeng","Yan, Tianzhong","32357275"],"abstract":["OBJECTIVE: To summarize measures for prevention and control of the 2019 novel Corona Virus Disease (COVID-19) in the department of kidney transplantation. METHODS: We retrospectively analyzed the clinical data of outpatients and inpatients in the department of kidney transplantation from January 20, 2020 to March 1, 2020, and followed up the in-home kidney transplant recipients and those waiting for kidney transplantation through the Internet platform. Our department had formulated detailed prevention and control measures, mainly including: kidney transplant outpatient management, kidney transplantation ward management, management of kidney transplant surgery, dialysis management of patients waiting for kidney transplantation, personal protection of medical staff, follow-up management of discharged patients after kidney transplantation, etc. RESULTS: During the epidemic period, there were no COVID-19 among 68 outpatient examined kidney transplant recipients, 32 hospitalized kidney transplant recipients, 19 patients waiting for kidney transplantation in hospital and 30 medical staff. There were no COVID-19 in the follow-up of 160 recipients after kidney transplantation and 60 patients waiting for kidney transplantation. CONCLUSION: During the epidemic period, we implemented strict prevention and control measures and adjusted working methods and procedures to ensure the safe and orderly work of the department."],"journal":"Transpl Int","authors":["Li, Yurong","Yang, Ning","Li, Xiaoxiao","Wang, Junpeng","Yan, Tianzhong"],"date":"2020-05-02T11:00:00Z","year":2020,"_id":"32357275","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1111/tri.13634","keywords":["2019 novel coronavirus disease","kidney transplant","pneumonia","prevention and control"],"topics":["Prevention"],"weight":1,"_version_":1666138495198953472,"score":9.490897,"similar":[{"pmid":32359188,"title":"Strategies to halt 2019 novel coronavirus (COVID-19) spread for organ transplantation programs at the Sichuan Academy of Medical Science and Sichuan Provincial People's Hospital, China.","text":["Strategies to halt 2019 novel coronavirus (COVID-19) spread for organ transplantation programs at the Sichuan Academy of Medical Science and Sichuan Provincial People's Hospital, China.","During the coronavirus outbreak in China, our center performed 16 organ transplants (10 kidney, 4 liver and 2 lung transplants, from January 24 to March 11, 2020) harvested from deceased donors. Regarding the strategies to prevent infections of COVID-19, we implemented specific measures for the donor and recipient management, as well as prevention of hospital-acquired infections. All 16 organ recipients had a favorable outcome without COVID-19 infection. Our approaches aiming to interrupt the spread of coronavirus within the transplantation wards were successful and allowed us to maintain the transplantation program for deceased liver, kidney and lung recipients.","Am J Transplant","Wang, Yi","Liu, Huirong","Buhler, Leo H","Deng, Shaoping","32359188"],"abstract":["During the coronavirus outbreak in China, our center performed 16 organ transplants (10 kidney, 4 liver and 2 lung transplants, from January 24 to March 11, 2020) harvested from deceased donors. Regarding the strategies to prevent infections of COVID-19, we implemented specific measures for the donor and recipient management, as well as prevention of hospital-acquired infections. All 16 organ recipients had a favorable outcome without COVID-19 infection. Our approaches aiming to interrupt the spread of coronavirus within the transplantation wards were successful and allowed us to maintain the transplantation program for deceased liver, kidney and lung recipients."],"journal":"Am J Transplant","authors":["Wang, Yi","Liu, Huirong","Buhler, Leo H","Deng, Shaoping"],"date":"2020-05-03T11:00:00Z","year":2020,"_id":"32359188","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1111/ajt.15972","locations":["China","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1666138495292276737,"score":700.4618},{"pmid":32423908,"title":"Early Outcomes of Outpatient Management of Kidney Transplant Recipients with Coronavirus Disease 2019.","text":["Early Outcomes of Outpatient Management of Kidney Transplant Recipients with Coronavirus Disease 2019.","BACKGROUND AND OBJECTIVES: Outcomes of kidney transplant recipients diagnosed with coronavirus disease 2019 as outpatients have not been described. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We obtained clinical data for 41 consecutive outpatient kidney transplant recipients with known or suspected coronavirus disease 2019. Chi-squared and Wilcoxon rank sum tests were used to compare characteristics of patients who required hospitalization versus those who did not. RESULTS: Of 41 patients, 22 (54%) had confirmed coronavirus disease 2019, and 19 (46%) were suspected cases. Patients most commonly reported fever (80%), cough (56%), and dyspnea (39%). At the end of follow-up, 13 patients (32%) required hospitalization a median of 8 days (range, 1-16) after symptom onset, and 23 (56%) had outpatient symptom resolution a median of 12 days (4-23) after onset. Patients who required hospitalization were more likely to have reported dyspnea (77% versus 21%, P=0.003) and had higher baseline creatinine (median, 2.0 versus 1.3 mg/dl, P=0.02), but there were no other differences between groups. CONCLUSIONS: In an early cohort of outpatient kidney transplant recipients with known or suspected coronavirus disease 2019, many had symptomatic resolution without requiring hospitalization.","Clin J Am Soc Nephrol","Husain, S Ali","Dube, Geoffrey","Morris, Heather","Fernandez, Hilda","Chang, Jae-Hyung","Paget, Kathryn","Sritharan, Sharlinee","Patel, Shefali","Pawliczak, Olga","Boehler, Mia","Tsapepas, Demetra","Crew, R John","Cohen, David J","Mohan, Sumit","32423908"],"abstract":["BACKGROUND AND OBJECTIVES: Outcomes of kidney transplant recipients diagnosed with coronavirus disease 2019 as outpatients have not been described. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We obtained clinical data for 41 consecutive outpatient kidney transplant recipients with known or suspected coronavirus disease 2019. Chi-squared and Wilcoxon rank sum tests were used to compare characteristics of patients who required hospitalization versus those who did not. RESULTS: Of 41 patients, 22 (54%) had confirmed coronavirus disease 2019, and 19 (46%) were suspected cases. Patients most commonly reported fever (80%), cough (56%), and dyspnea (39%). At the end of follow-up, 13 patients (32%) required hospitalization a median of 8 days (range, 1-16) after symptom onset, and 23 (56%) had outpatient symptom resolution a median of 12 days (4-23) after onset. Patients who required hospitalization were more likely to have reported dyspnea (77% versus 21%, P=0.003) and had higher baseline creatinine (median, 2.0 versus 1.3 mg/dl, P=0.02), but there were no other differences between groups. CONCLUSIONS: In an early cohort of outpatient kidney transplant recipients with known or suspected coronavirus disease 2019, many had symptomatic resolution without requiring hospitalization."],"journal":"Clin J Am Soc Nephrol","authors":["Husain, S Ali","Dube, Geoffrey","Morris, Heather","Fernandez, Hilda","Chang, Jae-Hyung","Paget, Kathryn","Sritharan, Sharlinee","Patel, Shefali","Pawliczak, Olga","Boehler, Mia","Tsapepas, Demetra","Crew, R John","Cohen, David J","Mohan, Sumit"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32423908","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.2215/CJN.05170420","keywords":["covid-19","cohort studies","dyspnea","nonparametric","outpatients","sars-cov2","statistics","coronavirus","creatinine","hospitalization","kidney transplantation","severe acute respiratory syndrome coronavirus 2"],"e_drugs":["Creatinine"],"topics":["Treatment","Diagnosis"],"weight":1,"_version_":1667252838008356864,"score":689.48804},{"pmid":32317402,"title":"Early Description of Coronavirus 2019 Disease in Kidney Transplant Recipients in New York.","text":["Early Description of Coronavirus 2019 Disease in Kidney Transplant Recipients in New York.","BACKGROUND: The novel SARS-CoV-2 virus has caused a global pandemic of coronavirus disease 2019 (COVID-19). Although immunosuppressed individuals are thought to be at an increased risk of severe disease, little is known about their clinical presentation, disease course, or outcomes. METHODS: We report 15 kidney transplant recipients from the Columbia University kidney transplant program who required hospitalization for confirmed COVID-19, and describe their management, clinical course, and outcomes. RESULTS: Patients presented most often with a fever (87%) and/or cough (67%). Initial chest x-ray most commonly showed bilateral infiltrates, but 33% had no acute radiographic findings. Patients were managed with immunosuppression reduction and the addition of hydroxychloroquine and azithromycin. Although 27% of our patients needed mechanical ventilation, over half were discharged home by the end of follow-up. CONCLUSIONS: Kidney transplant recipients with COVID-19 have presentations that are similar to that of the general population. Our current treatment protocol appears to be associated with favorable outcomes, but longer follow-up of a larger cohort of patients is needed.","J Am Soc Nephrol","32317402"],"abstract":["BACKGROUND: The novel SARS-CoV-2 virus has caused a global pandemic of coronavirus disease 2019 (COVID-19). Although immunosuppressed individuals are thought to be at an increased risk of severe disease, little is known about their clinical presentation, disease course, or outcomes. METHODS: We report 15 kidney transplant recipients from the Columbia University kidney transplant program who required hospitalization for confirmed COVID-19, and describe their management, clinical course, and outcomes. RESULTS: Patients presented most often with a fever (87%) and/or cough (67%). Initial chest x-ray most commonly showed bilateral infiltrates, but 33% had no acute radiographic findings. Patients were managed with immunosuppression reduction and the addition of hydroxychloroquine and azithromycin. Although 27% of our patients needed mechanical ventilation, over half were discharged home by the end of follow-up. CONCLUSIONS: Kidney transplant recipients with COVID-19 have presentations that are similar to that of the general population. Our current treatment protocol appears to be associated with favorable outcomes, but longer follow-up of a larger cohort of patients is needed."],"journal":"J Am Soc Nephrol","date":"2020-04-23T11:00:00Z","year":2020,"_id":"32317402","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1681/ASN.2020030375","keywords":["covid-19","epidemiology and outcomes","kidney transplantation","transplant outcomes"],"link_comment_in":"32345701","locations":["New York"],"countries":["United States"],"countries_codes":["USA|United States"],"e_drugs":["Hydroxychloroquine","Azithromycin"],"topics":["Treatment"],"weight":1,"_version_":1666138493647060993,"score":669.1555},{"pmid":32330356,"title":"Earliest cases of coronavirus disease 2019 (COVID-19) identified in solid organ transplant recipients in the United States.","text":["Earliest cases of coronavirus disease 2019 (COVID-19) identified in solid organ transplant recipients in the United States.","With the rapidly expanding pandemic of SARS-CoV-2, there is concern that solid organ transplant recipients will be particularly vulnerable to infection and may experience a more severe clinical course. We report four cases of COVID-19 in solid organ transplant recipients including recipients of kidney, liver, lung, and heart transplants. We describe each patient's medical history including transplantation history, their clinical presentation and workup, and their course from diagnosis to either hospital discharge or to improvement in symptoms. These reports demonstrate a range of symptoms, clinical severity, and disease course in solid organ transplant recipients with COVID-19, including two hospitalized patients and two patients managed entirely in the outpatient setting.","Am J Transplant","Kates, Olivia S","Fisher, Cynthia E","Stankiewicz-Karita, Helen C","Shepherd, Amanda K","Church, E Chandler","Kapnadak, Siddhartha G","Lease, Erika D","Riedo, Francis X","Rakita, Robert M","Limaye, Ajit P","32330356"],"abstract":["With the rapidly expanding pandemic of SARS-CoV-2, there is concern that solid organ transplant recipients will be particularly vulnerable to infection and may experience a more severe clinical course. We report four cases of COVID-19 in solid organ transplant recipients including recipients of kidney, liver, lung, and heart transplants. We describe each patient's medical history including transplantation history, their clinical presentation and workup, and their course from diagnosis to either hospital discharge or to improvement in symptoms. These reports demonstrate a range of symptoms, clinical severity, and disease course in solid organ transplant recipients with COVID-19, including two hospitalized patients and two patients managed entirely in the outpatient setting."],"journal":"Am J Transplant","authors":["Kates, Olivia S","Fisher, Cynthia E","Stankiewicz-Karita, Helen C","Shepherd, Amanda K","Church, E Chandler","Kapnadak, Siddhartha G","Lease, Erika D","Riedo, Francis X","Rakita, Robert M","Limaye, Ajit P"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32330356","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1111/ajt.15944","locations":["United States"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Case Report"],"weight":1,"_version_":1666138494612799488,"score":664.26154},{"pmid":32457133,"title":"The impact of the COVID-19 pandemic on renal transplantation in the UK.","text":["The impact of the COVID-19 pandemic on renal transplantation in the UK.","COVID-19 is impacting provision of renal transplantation in the UK with a reduction in clinical activity. Publicly available Renal Registry and NHS Blood and Transplant reports were analysed to model the number of missed transplant opportunities, waiting list size and change in dialysis population over a six-month period starting 5 March 2020. An estimated 1,670 kidney transplant opportunities may be lost, which will lead to 6,317 active patients on the kidney-alone waiting list, compared to 4,649 based on usual activity estimates. This will result in 1,324 additional patients on dialysis who would otherwise have been transplanted. COVID-19 will lead to a marked loss of transplant opportunities and a significantly larger national waiting list. The existing strain on dialysis capacity will be exacerbated as patients remain on dialysis as the only available form of renal replacement therapy. These findings will help inform policy and service specific strategies.","Clin Med (Lond)","Sharma, Videha","Shaw, Alex","Lowe, Marcus","Summers, Angela","van Dellen, David","Augustine, Titus","32457133"],"abstract":["COVID-19 is impacting provision of renal transplantation in the UK with a reduction in clinical activity. Publicly available Renal Registry and NHS Blood and Transplant reports were analysed to model the number of missed transplant opportunities, waiting list size and change in dialysis population over a six-month period starting 5 March 2020. An estimated 1,670 kidney transplant opportunities may be lost, which will lead to 6,317 active patients on the kidney-alone waiting list, compared to 4,649 based on usual activity estimates. This will result in 1,324 additional patients on dialysis who would otherwise have been transplanted. COVID-19 will lead to a marked loss of transplant opportunities and a significantly larger national waiting list. The existing strain on dialysis capacity will be exacerbated as patients remain on dialysis as the only available form of renal replacement therapy. These findings will help inform policy and service specific strategies."],"journal":"Clin Med (Lond)","authors":["Sharma, Videha","Shaw, Alex","Lowe, Marcus","Summers, Angela","van Dellen, David","Augustine, Titus"],"date":"2020-05-28T11:00:00Z","year":2020,"_id":"32457133","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.7861/clinmed.2020-0183","keywords":["covid-19","nhs","kidney transplantation","renal insufficiency","renal replacement therapy"],"locations":["GBR","Transplant","GBR"],"countries":["United Kingdom"],"countries_codes":["GBR|United Kingdom"],"topics":["Prevention"],"weight":1,"_version_":1667967699035095040,"score":647.6765}]}